Academic Enterprise Announcements

Headshot of Alan Landay on a teal background with a banner that says New AE Leadership Announcement

Dr. Alan Landay Joins UTMB as VP, Team Science

We are excited to share that Alan Landay, PhD, has joined UTMB as Vice President of Team Science, effective Feb. 1. In this role, he will bring research and clinical experts together to create collaborations at UTMB and with institutions across the region, state, and world. He also serves as Professor in the Departments of Internal Medicine and Microbiology & Immunology.

Dr. Landay most recently served Rush University as Vice Chair of Research and Division Chief of Translational and Precision Medicine in the Department of Internal Medicine.

Dr. Landay has been involved in HIV research for more than 42 years, having performed some of the first immune evaluations of HIV-infected hemophiliacs in 1981. With Abbott Labs he helped develop the first HIV antibody test licensed by the FDA in 1985 for use in screening the blood supply. His laboratory has made important original contributions in understanding the role of immune activation and inflammation in outcomes of non-communicable disease related to aging in the HIV population.

For more than 30 years Dr. Landay has been an investigator for the Advancing Clinical Therapeutics Network (ACTG), a global clinical trials network that conducts research to improve the management of HIV and its comorbidities; develop a cure for HIV; and innovate treatments for tuberculosis, hepatitis C, and emerging infectious diseases. Since its inception 20 years ago, he has led the Rush Immunology Support Lab.

Dr. Landay has extensive experience in aging-related studies. For the past 10 years, his research focus has been on studies of the human microbiome and metabolome and better understanding its role both in health and disease. More recently, Dr. Landay led the research effort for COVID-19 in the Department of Medicine at Rush, leading the establishment of the COVID-19 biorepository. He also leads the COVID-19 lab efforts for the NIH-funded ACTG Lab group. Additionally, he has extensive experience over the past 10 years working with laboratories in international settings in his role as Scientific Director of Labs for the NIH-funded ACTG Grant.

We are thrilled to have Dr. Landay on board. His expertise and experience will be critical to our ongoing endeavor to advance collaboration, innovation, and breakthrough science within our Research Enterprise.

Many thanks,

Charles P. Mouton, MD, MS, MBA
Executive Vice President, Provost, and Dean, John Sealy School of Medicine
Thomas N. and Gleaves P. James Distinguished Chair

Randall J. Urban, MD
Vice President and Chief Research Officer
Vice Dean, Clinical Research, John Sealy School of Medicine

We want your news!

If you know of an Academic Enterprise news item that should be featured here, please let us know! It could be an award, a new appointment, or a great opportunity open to others in the AE. 

Contact a member of our AE Communications team to let us know.

Headshot of Cortney Martin
Cortney Martin
Manager, Communications and Community Initiatives
Email • (409) 772-0081
Headshot of Ashley Torres
Ashley Torres
Communications Specialist
Email •
 (409) 266-4027

Follow us!Facebook iconTwitter icon